Aman, M., Lindsay, R., Nash, P., Arnold, L. (2003). H 46: Individuals with mental retardation. In: Martin, A., Scahill, L., Charney, D.S., Leckman, J.F. (2003)Pediatric Psychopharmacology, principles and Practice(pp 617-63). Oxford University Press
Aman, M.G., De Smedt, G., Derivan, A., Lyons, B., Findling, R.L. (2002). Risperidon Disruptive Behavior Study Group. Double-blind, placebo controlled study of risperidon for the treatment of disruptive behaviours in children with subaverage intelligence.American Journal Psychiatry; 159: 1337-1346
American Psychiatric Association (2013). Diagnostic and Statistical Manual of Mental Disorders (5th Ed.). Arlington, VA: American Psychiatric Publishing.
Barkley, R., McMurray, M., Edelbroch, C., Robbins, K. (1990). Side effects of MPH in children with attention deficit hyperactivity disorder: a systematic placebo-controlled evaluation.Pediatrics; 86: 184-192
Biederman, J., Spencer, T.J., Newcorn, J.H., Gao, H., Mitlon, D.R., Feldman, P.D., Witte, M.M. (2007). Effect of comorbid symptoms of oppositional defiant disorder on responses to atomoxetine in children with ADHD: a meta-analysis of controlled clinical trial data.Phsychopharmacology; 190: 31-41.
Campbell, M., Adams, P.B., Small, A.M., Kafantaris, V., Silva, R.R., Shell, J., Perry, R., Overall, J.E. (1995). Lithium in hospitalized aggressive children with conduct disorder: a double-blind and placebo-controlled study.Journalof the AmericanAcademyofChild&Adolescent Psychiatry; 34:445-453
Campbell, M., Small, A.M., Green, W.H., Jennings, S.J., Perry, R., Bennett, W,G., Anderson, L. (1984). Behavioral efficacy of haloperidol and lithium carbonate.Archives of General Psychiatry; 41:650-656
Cantwell, D., Swanson, J., Conner, D. (1997). Case study: adverse response to clonidine.Journalof the AmericanAcademyofChild&Adolescent Psychiatry; 36: 539-544
Comings, D., Comings, B., Tacket, T., Li, S. (1990). The clonidine patch and behaviour problems.Journalof the AmericanAcademyofChild&Adolescent Psychiatry; 29: 667-668
Connor, D., Barkley, R., Davis, H. (2000). A pilot study of methylphenidate, clonidine or the combination in ADHD comorbid with aggressive, oppositional defiant of conduct disorder.Clin Pediatr (Phila): 15-25
Connor DF, Findling RL, Kollins S, et al. (2010). Effects of guanfacine extended release on oppositional symptoms in children aged 6–12 years with attention-de cit hyperactivity disorder and oppositional symptoms: a randomized, double-blind, placebo-controlled trial. CNS Drugs. 24(9):755–768.
Cueva, J.E., Overall, J.E., Small, A.M., Armenteros, J.L., Perry, R., Campbell, M. (1996). Carbamazepine in aggressive children with conduct disorder: a double-blind and placebo-controlled study.Journalof the AmericanAcademyofChild&Adolescent Psychiatry; 35: 480-490
Donovan, S.J., Stewart, J.W., Nunes, E.V., Quitkin, P.M., Parides, M, Daniel, W., Susser, E., Klein, D.R. (2000). Divalproex treatment for youth with explosive temper and mood lability: a double-blind, placebo-controlled crossover design.American Journal of Psychiatry; 157: 818-820
Dunbar, F., Kusumakar, V., Daneman, D., Schulz, M. (2004). Growth and sexual maturation during long-term treatment with risperidone.American Journal of Psychiatry; 161: 918-920
Ercan, E.S., Kutlu, A., Cikoglu, S., Veznedaroglu, B., Erermis, S., Varan, A. (2003). Risperidone in Children and Adolescents with Conduct Disorder: A single-center, open label study.Current therapeutic research; 64: 1: 55-64
Findling, R., Aman, M., Eerdekens, M., Derivan, A., Lyons, B. (2004). The Risperidon Disruptive Behavior Group; Long term, open label study of Risperidon in Children with severe disruptive behavior and below average IQ.American Journal of Psychiatry; 161: 677-684
Findling, R., Fegert, J., De Smedt, G. (2002a). Risperidone in children with disruptive behaviors and subaverage IQ.European Psychiatry; 17: 118
Findling, R., Kusumakar, V., Daneman, D. (2002b). Normalization of prolactin levels in children with long-term risperidon treatment. 49th Annual Meeting of theAmerican Academy of Child and Adolescent Psychiatry; oct 22-27: San Fransisco
Findling, R., McNamara, N., Branicky, L., Schluchter, E., Lemon, E., Blumer, J. (2000). A double-blind pilot study of risperidone in the treatment of conduct disorder.Journal of the American Academy of Child & Adolescent Psychiatry; 39: 509-516
Gadow, K.D., Nolan, E.E., Sverd, J., Sprafkin, J., Schneider, J. (2008). Methylphenidate in children with oppositional defiant disorder and both comorbid chronic multiple tic disorder and ADHD.Journal of Child Neurology; 23(9): 981-990.
Hunt, R., Capper, L., O’Connell, P. (1990). Clonidine in child and adolescent psychiatry.Journal of Child and Adolescent Psychopharmacology; 1: 87-102
Kaplan, S., Heiligenstein, J., West, S., Harder, D., Dittman, R., Casat, C., Wernicke, J.F. (2004). Efficacy and safety of atomoxetine in childhood attention-deficit/hyperactivity disorder with comorbid oppositional defiant disorder.Journal of Attention Disorder; 8: 2: 45-52
Kemph, J., DeVane, C., Levin, G., Jarecke, R., Miller, R. (1993). Treatment of aggressive children with clonidine: results of an open pilot study.Journal of American Academy of Child and Adolescent Psychiatry; 32: 577-581
Klein, R.G., Abikoff, H., Klass, E., Ganales, D., Seese, L.M., Pollack S. (1997). Clinical efficacy of methylphenidate in conduct disorder with and without attention deficit hyperactivity disorder.Archives of General Psychiatry; 54:1073-1080
Klein, R.G. (1991). Preliminary results: lithium effects in conduct disorder. In:CME Syllabus and Proceeding Summary, Symposium 2: The 144th Annual Meeting of the American Psychiatric Association, New Orleans (pp. 119-120), LA. May 11-16. Washington, DC: American Psychiatric Association
Kutcher, S., Aman, M., Brooks, S., Buitelaar, J., van Daalen, E., Fegert, J., Findling, R., Fisman, S., Greenhill, L., Huss, M., Kusumakar, V., Pine, D., Taylor, E., Tyano, S. (2004). International Consensus statement on attention-deficit/hyperactivity disorder (ADHD) and disruptive behavior disorders (DBDs): Clinical implications and treatment practice suggestions.European Neuropsychofarmacology; 14: 11-28
Laforett, D.R., Murray, D.W., & Kollins, S.H. (2008). Psychosocial treatments for preschool-aged children with Attention-Deficit Hyperactivity Disorder. Developmental Disabilities Research Reviews, 14, (4), 300-310. https://doi.org/10.1002/ddrr.36
Malone, R.P., Delaney, M.A., Luebbert, J.F., Cater, J., Campbell, M. (2000). A double-blind placebo-controlled study of lithium in hospitalized aggressive children and adolescents with conduct disorder.Archives General Psychiatry; 57: 649-654
Matthys, W. (2019). Diagnostiek en behandeling van gedragsproblemen bij kinderen. Amsterdam: Hogrefe.
Matthys, W. & Glind, G. van de (2013).Oppositioneel opstandige stoornis (ODD) en gedragsstoornis (CD) bij kinderen en jongeren.Utrecht: de Tijdstroom.
Matthys, W. & Glind, G. van de (2013). Richtlijn Oppositioneel opstandige stoornis (ODD) en gedragsstoornis (CD) bij kinderen en jongeren. Utrecht: Nederlandse Vereniging voor Psychiatrie, de Tijdstroom.
Matthys, W., & Lochman, J.E. (2010).Oppositional defiant disorder and conduct disorder in childhood.Chicester: Wiley-Blackwell.
Newcorn, J., Schulz Halperin, J. (2003). H 21: Adrenergic agonists: clonidine and guanfacine. In:Pediatric Psychopharmacology, principles and Practice. Ed: Martin A ea, Oxford University Press; 264-273
Newcorn, J., Spencer, T., Biederman, J., Milton, D., Michelson, D. (2005). Atomoxetine Treatment in Children and Adolescents With Attention Deficit/Hyperactivity Disorder and Comorbid Oppositional Defiant Disorder.Journal American Academy Child of Adolescent Psychiatry; 44: 3: 240-248
Overbeek, W.A., Vroede, M.A.M. de, Lahuis, B.E., Hillegers, M.H.J., & Graeff-Meeder, E.R. de (2010). Antipsychotica en metabole afwijkingen bij kinderen en adolescenten; een literatuuroverzicht en aanbevelingen voor de praktijk. Tijdschrift voor Psychiatrie, 52, 311-320.
Popma, A., Vermeiren, R., Geluk, C.A., Rinne, T., van den Brink, W., Knol, D.L., Jansen, L.M.C., van Engeland, H., & Doreleijers, T.A.H. (2007). Cortisol moderates the relationship between testosterone and aggression in delinquent male adolescents. Biological Psychiatry, 61, 405-411.
Reeves, G. M., Wehring, H. J., & Riddle, M. A. (2018). Pharmacotherapy of disruptive and impulse control disorders. In In J.E. Lochman and W. Matthys (Eds.). The Wiley Handbook of Disruptive and Impulsive-Disorders (pp. 411- 432). Chichester: Wiley-Blackwell.
Rifkin, A., Karajgi, B., Dicker, R., Perl, E., Boppona, V., Hasan, N., Pollack, S. (1997). Lithium treatment of conduct disorders in adolescents.American Journal Psychiatry; 154: 554-555
Schur, S., Sikich, L., Findling, R., Malone, R., Crismon, M., Derivan, A., Macintyre, J., Pappadopulos, R.E., Greenhill, L., Schooler, N., van Orden, K., Jensen, P. (2003). Treatment Recommendations for the Use of Antipsychotics for Agressive Youth (TRAAY). Part I: A Review.Journal of American Academy Child and Adolscent Psychiatry; 42(2): 132-144
Sinzig, J., Döpfner, M., Lehmkuhl, G., German Methylphenidate Study Group, Uebel, H., Schmeck, K., et al. (2007). Long-acting Methylphenidate has an effect on aggressive behaviour in children with attention-deficit/hyperactivity disorder.Journal of Child and Adolescent Psychopharmocology; 17(4): 421-432.
Snyder R, Turgay A, Aman MG. (2002). Effects of risperidone on conduct disorder and disruptive behaviour disorders in children with subaverage IQs.Journalof the AmericanAcademyofChild&Adolescent Psychiatry; 41: 1026-1036
Swanson, J.M. (1995).SNAP-IV Scale. Child Development Center, UC Irvine
Taylor, E., Dopfner, M., Sergeant, J., Asherson, P., Banaschewski, T., Buitelaar, J., Coghill, D., Dankaerts, M., Rothenberger, A., Sonuga-Barke, E., Steinhausen. H., Zuddas, A. (2004). European clinical guidelines for hyperkinetic disorder-first upgrade.European ChildandAdolescent Psychiatry(suppl 1); 13: 1/7-1/30.
Taylor, E., Schachar, R., Thorley, G., Wieselberg, H.M., Everitt, B., & Rutter, M. (1987). Which boys respond to stimulant medication? A controlled trial of methylphenidate in boys with disruptive behaviour.Psychological Medicine,17, 121-143.
Turgay, A. (2009). Psychopharmalogical treatment op oppositional defiant disorder.CNS Drugs; 23(1): 1-17. Buitelaar, J.K., Van der Gaag, R.J., Cohen-Kettenis, P., Melman, C.T.M. (2001). A randomized controlled trial of risperidone in the treatment of aggresson in hospitalized adolescents with subaverage cogitive abilities.Journal of Clinical Psychiatry; 62: 239-248
Turgay, E., Snyder, R., Binder, C., Fisman, S., Carrol, A. (2002). Risperidone in children with subaverage IQ and behavior diorders.European Psychiatry; 17: 118
Wilens T, Bukstein O, Brams M, et al. A controlled trial of extended-release guanfacine and psychostimulants for attention- deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2012;51(1):74–85.
Zero to Three (2016). Diagnostic Classification of Mental Health and Developmental Disorders of Infancy and Early Childhood: DC:0-5). Washington, DC: ZERO TO THREE.
